View in EDS HTML Full Text PDF Full Text

Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma.

Saved in:
Bibliographic Details
Title: Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma.
Authors: Holdhoff M; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Ye X; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Strowd RE; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA., Nabors B; University of Alabama, Birmingham, Alabama, USA., Walbert T; Henry Ford Hospital, Detroit, Michigan, USA., Lieberman FS; University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Bagley SJ; University of Pennsylvania, Philadelphia, Pennsylvania, USA., Fiveash JB; University of Alabama, Birmingham, Alabama, USA., Fisher JD; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Desideri S; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Surakus T; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Engelhardt M; Basilea Pharmaceutica International Ltd, Allschwil, Switzerland., Kaindl T; Basilea Pharmaceutica International Ltd, Allschwil, Switzerland., Lane HA; Basilea Pharmaceutica International Ltd, Allschwil, Switzerland., Litherland K; Basilea Pharmaceutica International Ltd, Allschwil, Switzerland., Grossman SA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA., Kleinberg LR; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.
Source: Neuro-oncology advances [Neurooncol Adv] 2024 Aug 28; Vol. 6 (1), pp. vdae150. Date of Electronic Publication: 2024 Aug 28 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39371261
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Holdhoff+M%22">Holdhoff M</searchLink>; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Ye+X%22">Ye X</searchLink>; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Strowd+RE%22">Strowd RE</searchLink>; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Nabors+B%22">Nabors B</searchLink>; University of Alabama, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Walbert+T%22">Walbert T</searchLink>; Henry Ford Hospital, Detroit, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Lieberman+FS%22">Lieberman FS</searchLink>; University of Pittsburgh, Pittsburgh, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Bagley+SJ%22">Bagley SJ</searchLink>; University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Fiveash+JB%22">Fiveash JB</searchLink>; University of Alabama, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Fisher+JD%22">Fisher JD</searchLink>; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Desideri+S%22">Desideri S</searchLink>; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Surakus+T%22">Surakus T</searchLink>; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Engelhardt+M%22">Engelhardt M</searchLink>; Basilea Pharmaceutica International Ltd, Allschwil, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kaindl+T%22">Kaindl T</searchLink>; Basilea Pharmaceutica International Ltd, Allschwil, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lane+HA%22">Lane HA</searchLink>; Basilea Pharmaceutica International Ltd, Allschwil, Switzerland.<br /><searchLink fieldCode="AU" term="%22Litherland+K%22">Litherland K</searchLink>; Basilea Pharmaceutica International Ltd, Allschwil, Switzerland.<br /><searchLink fieldCode="AU" term="%22Grossman+SA%22">Grossman SA</searchLink>; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Kleinberg+LR%22">Kleinberg LR</searchLink>; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101755003%22">Neuro-oncology advances</searchLink> [Neurooncol Adv] 2024 Aug 28; Vol. 6 (1), pp. vdae150. <i>Date of Electronic Publication: </i>2024 Aug 28 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101755003 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-2498 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226322498%22">26322498 </searchLink><i>NLM ISO Abbreviation: </i>Neurooncol Adv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39371261
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/noajnl/vdae150
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: vdae150
    Titles:
      – TitleFull: Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Holdhoff M
      – PersonEntity:
          Name:
            NameFull: Ye X
      – PersonEntity:
          Name:
            NameFull: Strowd RE
      – PersonEntity:
          Name:
            NameFull: Nabors B
      – PersonEntity:
          Name:
            NameFull: Walbert T
      – PersonEntity:
          Name:
            NameFull: Lieberman FS
      – PersonEntity:
          Name:
            NameFull: Bagley SJ
      – PersonEntity:
          Name:
            NameFull: Fiveash JB
      – PersonEntity:
          Name:
            NameFull: Fisher JD
      – PersonEntity:
          Name:
            NameFull: Desideri S
      – PersonEntity:
          Name:
            NameFull: Surakus T
      – PersonEntity:
          Name:
            NameFull: Engelhardt M
      – PersonEntity:
          Name:
            NameFull: Kaindl T
      – PersonEntity:
          Name:
            NameFull: Lane HA
      – PersonEntity:
          Name:
            NameFull: Litherland K
      – PersonEntity:
          Name:
            NameFull: Grossman SA
      – PersonEntity:
          Name:
            NameFull: Kleinberg LR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 08
              Text: 2024 Aug 28
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2632-2498
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Neuro-oncology advances
              Type: main
ResultId 1